These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
687 related items for PubMed ID: 17457794
21. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective. Tremlett HL, Oger J. Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392 [Abstract] [Full Text] [Related]
22. [Spontaneous reports on unwanted drug effects in the years 1978-1979]. Ochsenfahrt H, Meyer zur Heyde M. Fortschr Med; 1981 Nov 12; 99(42):1753-8. PubMed ID: 7308935 [Abstract] [Full Text] [Related]
23. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Ramesh M, Pandit J, Parthasarathi G. Pharmacoepidemiol Drug Saf; 2003 Dec 12; 12(8):687-92. PubMed ID: 14762985 [Abstract] [Full Text] [Related]
24. [Reporting of adverse drug reactions in Iceland in 1999 to 2004]. Jóhannsson M, Agústsdóttir E. Laeknabladid; 2006 Apr 12; 92(4):283-7. PubMed ID: 16582456 [Abstract] [Full Text] [Related]
25. ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs. Egberts AC, de Koning FH, Meyboom RH, Leufkens HG. Pharmacoepidemiol Drug Saf; 1997 Jul 12; 6(4):269-76. PubMed ID: 15073778 [Abstract] [Full Text] [Related]
26. Multidisciplinary program for detecting and evaluating adverse drug reactions. Keith MR, Bellanger-McCleery RA, Fuchs JE. Am J Hosp Pharm; 1989 Sep 12; 46(9):1809-12. PubMed ID: 2801715 [Abstract] [Full Text] [Related]
27. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Br J Clin Pharmacol; 2007 Feb 12; 63(2):148-56. PubMed ID: 17274788 [Abstract] [Full Text] [Related]
28. Incidence of adverse drug reactions in adult medical inpatients. Bowman L, Carlstedt BC, Black CD. Can J Hosp Pharm; 1994 Oct 12; 47(5):209-16. PubMed ID: 10172139 [Abstract] [Full Text] [Related]
29. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J. Pharmacoepidemiol Drug Saf; 2009 Mar 12; 18(3):240-5. PubMed ID: 19148880 [Abstract] [Full Text] [Related]
30. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs. Jarernsiripornkul N, Krska J, Pongmanachai M, Nasritha N. Pharmacoepidemiol Drug Saf; 2009 Sep 12; 18(9):837-41. PubMed ID: 19548223 [Abstract] [Full Text] [Related]
31. Developing an adverse drug reaction reporting system at a teaching hospital. Baniasadi S, Fahimi F, Shalviri G. Basic Clin Pharmacol Toxicol; 2008 Apr 12; 102(4):408-11. PubMed ID: 18312492 [Abstract] [Full Text] [Related]
32. Food and Drug Administration monitoring of adverse drug reactions. Sills JM, Tanner LA, Milstien JB. Am J Hosp Pharm; 1986 Nov 12; 43(11):2764-70. PubMed ID: 3799612 [Abstract] [Full Text] [Related]
33. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center. Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S. Pharmacoepidemiol Drug Saf; 2007 Feb 12; 16(2):229-37. PubMed ID: 17063533 [Abstract] [Full Text] [Related]
34. A survey of adverse drug reaction reporting programs in select hospitals. Case RL, Guzzetti PJ. Hosp Pharm; 1986 May 12; 21(5):423-6, 431-4, 438. PubMed ID: 10276799 [Abstract] [Full Text] [Related]
35. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center. Mey C, Hentschel H, Hippius M, Balogh A. Int J Clin Pharmacol Ther; 2002 Mar 12; 40(3):102-7. PubMed ID: 11911597 [Abstract] [Full Text] [Related]
36. Survey of drug-related problems identified by community pharmacies. Hämmerlein A, Griese N, Schulz M. Ann Pharmacother; 2007 Nov 12; 41(11):1825-32. PubMed ID: 17925500 [Abstract] [Full Text] [Related]
37. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting. Christensen ST, Søndergaard B, Honoré PH, Bjerrum OJ. Pharmacoepidemiol Drug Saf; 2011 Apr 12; 20(4):399-404. PubMed ID: 21442686 [Abstract] [Full Text] [Related]
38. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre. Nicol C, Moulis F, Bondon-Guitton E, Durrieu G, Montastruc JL, Bagheri H. Therapie; 2019 Oct 12; 74(5):521-525. PubMed ID: 31029402 [Abstract] [Full Text] [Related]
39. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J, Ribeiro-Vaz I, Pereira AC, Polónia J. Int J Pharm Pract; 2014 Aug 12; 22(4):275-82. PubMed ID: 24188533 [Abstract] [Full Text] [Related]
40. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Aziz Z, Siang TC, Badarudin NS. Pharmacoepidemiol Drug Saf; 2007 Feb 12; 16(2):223-8. PubMed ID: 16947117 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]